Back to Results
First PageMeta Content
Microbiology / Bacterial diseases / Antibiotics / Occupational diseases / Antibiotic-resistant bacteria / Methicillin-resistant Staphylococcus aureus / Antibiotic resistance / Panton-Valentine leukocidin / ST8:USA300 / Bacteria / Staphylococcaceae / Medicine


Comparison of Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in Canada: CANWARD[removed]C2[removed]
Add to Reading List

Document Date: 2014-02-24 11:18:11


Open Document

File Size: 285,31 KB

Share Result on Facebook

City

Winnipeg / Chicago / /

Company

Janssen-Ortho Inc. / Merck Canada / Sepracor Pharmaceuticals Inc. / MRSA / Bayer Canada / Abbott Laboratories / Astellas Pharma Inc. / Pfizer Canada Inc. / /

Country

United States / Canada / /

/

Facility

Health Sciences Centre / CANWARD hospital / Maritimes Hospital / University of Manitoba2 / /

IndustryTerm

healthcare / /

Organization

University of Manitoba2 / FDA / Canadian Antimicrobial Resistance Alliance / /

Person

Alberta Saskatchewan / M.R. BAXTER / Kim Nichol / /

/

Position

D.J. / /

Product

levofloxacin / cefazolin / trimethoprim / linezolid / cefoxitin / clarithromycin / ciprofloxacin / sulfamethoxazole / /

ProvinceOrState

Quebec / Manitoba / Illinois / British Columbia / Ontario / /

PublishedMedium

Antimicrobial Agents and Chemotherapy / /

Technology

Chemotherapy / Genotype / /

SocialTag